PMID- 9686345 OWN - NLM STAT- MEDLINE DCOM- 19981008 LR - 20190831 IS - 0141-8955 (Print) IS - 0141-8955 (Linking) VI - 21 Suppl 1 DP - 1998 TI - Regulation of the urea cycle enzyme genes in nitric oxide synthesis. PG - 59-71 AB - Nitric oxide (NO) is synthesized from arginine by nitric-oxide synthase (NOS), and citrulline that is generated can be recycled to arginine by argininosuccinate synthase (AS) and argininosuccinate lyase (AL). Rats were injected with bacterial lipopolysaccharide (LPS) and expression of the inducible isoform of NOS (iNOS), AS and AL was analysed. In RNA blot analysis, iNOS mRNA was induced by LPS in the lung, heart, liver and spleen, and less strongly in the skeletal muscle and testis. AS and AL mRNAs were induced in the lung and spleen. Kinetic studies showed that iNOS mRNA increased rapidly in both spleen and lung, reached a maximum 2-5 h after the treatment, and decreased thereafter. On the other hand, AS mRNA increased more slowly and reached a maximum in 6-12 h (by about 10-fold in the spleen and 2-fold in the lung). AL mRNA in the spleen and lung increased slowly and remained high up to 24 h. In immunohistochemical analysis, macrophages in the spleen that were negative for iNOS and AS before LPS treatment were strongly positive for both iNOS and AS after this treatment. As iNOS, AS and AL were co-induced in rat tissues and cells, citrulline-arginine recycling seems to be important in NO synthesis under the conditions of stimulation. Arginine is a common substrate of NOS and arginase. Rat peritoneal macrophages were cultured in the presence of LPS and expression of iNOS and livertype arginase (arginase I) was analysed. mRNAs for iNOS and arginase I were induced by LPS in a dose-dependent manner. iNOS mRNA appeared 2 h after LPS treatment and increased up to a near-maximum at 8-12 h. On the other hand, arginase I mRNA began to increase after 4 h with a lag time and reached a maximum at 12 h. Immunoblot analysis showed that iNOS and arginase I proteins were also induced. Induction of iNOS and arginase I mRNAs were also observed in LPS-injected rats in vivo. Thus, arginase I appears to have an important role in downregulating NO synthesis in murine macrophages by decreasing the availability of arginine. A cDNA for human arginase II, an arginase isozyme, was isolated. A polypeptide of 354 amino acid residues including the putative NH2-terminal presequence for mitochondrial import was predicted. It was 59% identical with arginase I. mRNA for human arginase II was present in the kidney and other tissues but was not detected in the liver. Arginase II mRNA was co-induced with iNOS mRNA in murine macrophage-like RAW 264.7 cells by LPS. This induction was enhanced by dexamethasone and dibutyrul cAMP, and was prevented by interferon-gamma. These results indicate that NO synthesis is regulated by arginine-synthesizing and -degrading enzymes in a complicated manner. FAU - Mori, M AU - Mori M AD - Department of Molecular Genetics, Kumamoto University School of Medicine, Japan. FAU - Gotoh, T AU - Gotoh T FAU - Nagasaki, A AU - Nagasaki A FAU - Takiguchi, M AU - Takiguchi M FAU - Sonoki, T AU - Sonoki T LA - eng PT - Journal Article PL - United States TA - J Inherit Metab Dis JT - Journal of inherited metabolic disease JID - 7910918 RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Messenger) RN - 31C4KY9ESH (Nitric Oxide) RN - 7S5I7G3JQL (Dexamethasone) RN - 82115-62-6 (Interferon-gamma) RN - E0399OZS9N (Cyclic AMP) RN - EC 1.14.13.39 (NOS2 protein, human) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nos2 protein, rat) RN - EC 3.5.3.1 (Arginase) RN - EC 4.3.2.1 (Argininosuccinate Lyase) RN - EC 6.3.4.5 (Argininosuccinate Synthase) SB - IM MH - Amino Acid Sequence MH - Animals MH - Arginase/*genetics/metabolism MH - Argininosuccinate Lyase/*genetics MH - Argininosuccinate Synthase/*genetics/metabolism MH - Cell Line MH - Cyclic AMP/pharmacology MH - Dexamethasone/pharmacology MH - Enzyme Induction MH - Humans MH - Interferon-gamma/pharmacology MH - Lipopolysaccharides/pharmacology MH - Lung/metabolism MH - Molecular Sequence Data MH - Nitric Oxide/*biosynthesis MH - Nitric Oxide Synthase/*genetics/metabolism MH - Nitric Oxide Synthase Type II MH - Peritoneum MH - RNA, Messenger/genetics/metabolism MH - Rats MH - Sequence Alignment MH - Spleen/metabolism MH - Transcriptional Activation EDAT- 1998/08/01 00:00 MHDA- 1998/08/01 00:01 CRDT- 1998/08/01 00:00 PHST- 1998/08/01 00:00 [pubmed] PHST- 1998/08/01 00:01 [medline] PHST- 1998/08/01 00:00 [entrez] AID - 10.1023/a:1005357608129 [doi] PST - ppublish SO - J Inherit Metab Dis. 1998;21 Suppl 1:59-71. doi: 10.1023/a:1005357608129.